Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
1 other identifier
interventional
150
1 country
1
Brief Summary
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2023
CompletedFirst Posted
Study publicly available on registry
March 29, 2023
CompletedStudy Start
First participant enrolled
January 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
December 11, 2025
December 1, 2025
3.1 years
March 15, 2023
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Mortality or Hospital Readmission
Binary outcome; determined by review of patient electronic health record (EHR) data at Month 6.
Month 6
Secondary Outcomes (4)
12-Item Short Form Survey (SF-12) Score
Baseline
12-Item Short Form Survey (SF-12) Score
Month 6
Seattle Angina Questionnaire Short-Form (SAQ-7)
Baseline
Seattle Angina Questionnaire Short-Form (SAQ-7)
Month 6
Study Arms (1)
Geriatric Assessments using GeriKit App
EXPERIMENTALParticipants will receive comprehensive geriatric assessment via GeriKit app at baseline. All participants will complete a follow-up assessment via phone at 6 months. 20 of the 150 enrolled participants will continue onto a qualitative questionnaire after the completion of the 6-month follow up call.
Interventions
Digital health app used for comprehensive geriatric assessment (CGA). The app includes a series of brief, well-validated instruments: the MiniCog, 30-Second Chair Stand, Activities of Daily Living, Instrumental Activities of Daily Living, Patient Health Questionnaire (PHQ-9), Mini Nutrition Assessment, 2-Item Fall Screen, and Polypharmacy screen.
Eligibility Criteria
You may qualify if:
- Age ≥ 75
- Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks
- Capable of self-consent
- Understand and are able to perform study procedures in English
You may not qualify if:
- Non-ambulatory
- Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia)
- Unable or unwilling to consent
- Incarcerated
- Unable to use complete assessments in English
- Unable to complete geriatric assessment for other reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NYU Langone Healthlead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John A. Dodson, MD, MPH, FACC
NYU Langone Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2023
First Posted
March 29, 2023
Study Start
January 18, 2024
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
December 11, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to cdhlab@nyumc.org. To gain access, data requestors will need to sign a data access agreement.
The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: cdhlab@nyumc.org. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.